Typhoon Noul, China's strongest landfall this year, threatens regional supply chains and markets. What professionals need to know about cascading economic risks.
Thalapathy Vijay's 'Jana Nayagan' crosses Rs 100cr net in record time. What this tells us about entertainment sector recovery and consumer spending patterns in 2026.
Dr Reddy's and Cipla face US market headwinds in June quarter. Profit drops offset by strong domestic growth. What it means for your pharma portfolio.
Google's Gemini suggestions cluttering your workflow? Here's exactly how to turn off AI writing prompts in Google Docs permanently.
US FDA approves first oral PCSK9 inhibitor to replace injectable treatments for high cholesterol. What this means for pharma markets and patient care.
Read Full StoryCJI Surya Kant warns arbitration has lost speed advantage over litigation. What this means for dispute resolution and your business costs in 2026.
Read Full Analysis